Advertisement
Canada markets open in 54 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7302
    +0.0004 (+0.06%)
     
  • CRUDE OIL

    83.30
    +0.49 (+0.59%)
     
  • Bitcoin CAD

    87,403.12
    -3,869.95 (-4.24%)
     
  • CMC Crypto 200

    1,361.83
    -20.75 (-1.50%)
     
  • GOLD FUTURES

    2,338.50
    +0.10 (+0.00%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6600
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,467.75
    -196.75 (-1.11%)
     
  • VOLATILITY

    16.34
    +0.37 (+2.32%)
     
  • FTSE

    8,103.56
    +63.18 (+0.79%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6819
    0.0000 (0.00%)
     

Stocks in play: Fennec Pharmaceuticals Inc.

Reported financial results for the fiscal year ended December 31, 2018. Cash and cash equivalents were $22.8 million as of December 31, 2018. Net losses for the year were $9.9 million ($0.52 per share), compared to $7.0 million ($0.47 per share), respectively, for the same period in 2017. Fennec Pharmaceuticals Inc. shares T.FRX are trading down $0.72 at $8.33.